NVO Novo-Nordisk A/S
- 134.030
- -1.130-0.84%
- 136.700
- +2.670+1.99%
Novo-Nordisk A/S News
Novo Nordisk (NVO.US) Danish headquarters fire has been extinguished. The affected buildings are not being used for production
The fire at Novo Nordisk's Danish headquarters has been extinguished. This is the pharmaceutical company's second fire in less than a week.
Novo Nordisk's Weekly Insulin Flagged for Low Blood Sugar Risk
Pharmaceutical company Novo Nordisk's (NOVO-B.CO) weekly insulin was flagged by the US Food and Drug Administration with a higher risk of low blood sugar in patients with type 1 diabetes, Reuters repo
Novo Nordisk: Four core areas, strong foundation and innovation, responding to patients' needs
BEIJING, China, May 21, 2024 — Today, Novo Nordisk, the world's leading biopharmaceutical company, hosted its annual media conference. Novo Nordisk, which has just gone through the century, has anchored an innovative direction around a clear corporate strategy, focused on four core areas, built a deep and broad R&D pipeline, and invested in unprecedented production capacity to fully meet the growing medical needs of patients around the world. Novo Nordisk Global President and CEO Lars Fruergaard Jørgensen (Lars Fruergaard Jørgensen) Novo Nordisk's corporate strategy is rooted in “driving change and working together to defeat diabetes and its
Top Gap Ups and Downs on Wednesday: ADI, TJX, SCCO and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here's How. -- Barrons.com
By Josh Nathan-Kazis A plan by Hims & Hers Health to sell legal copies of Novo Nordisk's weight loss drug Wegovy is drawing pushback from the industry, and bringing new attention to an area of concer
Novo Nordisk Once-Weekly Insulin Icodec Poses Hypoglycemia Risk, FDA Says
Novo Nordisk's (NVO) insulin icodec for diabetes patients has an increased risk of causing low blood sugar levels, the US Food and Drug Administration said in a briefing document. "The highest risk pe
Top Research Reports for Novo Nordisk, QUALCOMM & Caterpillar
NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success
NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) shares were down more than 6% at last check Wednesday.The Boston-based company announced preclinical data for its novel "G-Protein-Coupled Receptor 119 (GPR11
NeuroBo Says DA-1241, Wegovy Combo Shows Potential in Treating MASH
Express News | U.S FDA Staff Reviewers Raise Concerns Of Risk Of Low Blood Sugar In Patients Treated With Novo Nordisk's Weekly Insulin
Express News | Novo Nordisk Reports Fire At Danish Headquarters Under Control; Office Building 'Not Able To Be Saved'
Is diet drug production capacity affected? Novo Nordisk (NVO.US) had two fire incidents in a week
Pharmaceutical giant Novo Nordisk's headquarters in Denmark caught fire, the second such incident in less than a week.
Hims & Hers Cut to Neutral at Citi on Recent Rally
Novo Nordisk Hit by Second Fire in a Week
By Dominic Chopping Emergency crews are fighting a fire at a Novo Nordisk facility for the second time in a week. The Danish pharmaceutical giant said Wednesday that a blaze started outside a buildi
Express News | Reuters Reported Novo Nordisk Site In Denmark Hit By Fire
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
The Structure Therapeutics (NASDAQ:GPCR) stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential.What Happened: JPMorgan
Australia bans pharmacies from producing generic versions of “weight loss magic drugs”
Australia will ban pharmacies from producing replicas of popular diet pills such as Ozempic. Earlier reports claimed that these drugs had dangerous side effects, including one patient being hospitalized due to a “serious adverse event.” Australian Health Minister Mark Butler said in a statement on Wednesday that pharmacies will be restricted from producing complex GLP-1 receptor agonist products for individual patients — a class of drugs to help control blood sugar levels. The bug previously allowed the production of products similar to Ozempic that were not approved by Australian regulators. According to Butler, more than 20,000 Australian patients have been using this analogy
Australia to Ban Copycats of Ozempic Weight Loss Medication
Australia will ban pharmacies from creating replicas of popular weight loss drugs like Ozempic, following reports of dangerous side effects including one patient’s hospitalization for a “serious adverse incident.”
Top Gap Ups and Downs on Tuesday: LLY, AZN, NTES and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Most Patients Discontinue Weight-Loss Drugs in US Before Health Benefits Show, Report Says
Majority of patients in the US who started weight-loss drug treatment discontinued the treatment before realizing a "clinically meaningful health benefit," according to study by Blue Cross Blue Shield
Analysis
Price Target
No Data
